89bio Inc. (ETNB) Appoints E. Morrey Atkinson to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. WDC
2. RNG
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. BE
9. AXP
10. NDAQ

Go back to 89bio Inc. (ETNB) Appoints E. Morrey Atkinson to its Board

89bio Announces Appointment of E. Morrey Atkinson, Ph.D., to its Board of Directors

February 24, 2022 8:00 AM EST

SAN FRANCISCO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the appointment of E. Morrey Atkinson, Ph.D., to its Board of Directors. Dr. Atkinson currently serves as Senior Vice President, Head of Commercial Manufacturing and Supply Chain of Vertex Pharmaceuticals.

As a seasoned biopharmaceutical industry veteran with deep-rooted expertise, Morrey is a welcome addition to our Board of Directors," said Rohan Palekar, Chief Executive Officer of 89bio. "Morrey brings... More